Doseology Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DOSEF research report →
Companydoseology.com
Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. It focuses on research, development, and sale of medicinal mushroom products, including tinctures and powders.
- CEO
- Christopher Jackson
- IPO
- 2022
- HQ
- Kelowna, BC, CA
Price Chart
Valuation
- Market Cap
- $1.43M
- P/E
- -4.06
- P/S
- 24.38
- P/B
- 2.56
- EV/EBITDA
- -1.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -136.69%
- Op Margin
- -1096.30%
- Net Margin
- -1068.58%
- ROE
- -63.21%
- ROIC
- -64.56%
Growth & Income
- Revenue
- $31.26K · -68.27%
- Net Income
- $-328,900 · 3.22%
- EPS
- $-0.07 · 10.75%
- Op Income
- $-346,394
- FCF YoY
- -45.56%
Performance & Tape
- 52W High
- $1.50
- 52W Low
- $0.01
- 50D MA
- $0.44
- 200D MA
- $0.65
- Beta
- 2.32
- Avg Volume
- 837
Get TickerSpark's AI analysis on DOSEF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DOSEF Coverage
We haven't published any research on DOSEF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DOSEF Report →